A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers
International Wound Journal, EarlyView.
CONCLUSIONS The D-ADM demonstrated the ability to rapidly reduce the size of large, complex DFUs with exposed bone. Some wounds did not completely heal by 16 weeks; however, the significant reduction in size suggests that these large, complex wounds may heal if given more time.
Conclusions: It was concluded that aseptically processed dHACA heals diabetic foot wounds more reliably, statistically significantly faster than and at significantly lower cost than TESS.
Conditions: Diabetic Foot; Ulcer Foot Interventions: Other: Human split thickness skin allograft; Other: Additional Outer Dressing Applicaiton; Other: Offloading; Other: Fibracol Wound Dressing Sponsors: Professional Education and Research Institute; Solsys Medical LLC Not yet recruiting
Condition: Determine Effectiveness of Theraskin in the Treatment of DFU and VLU Intervention: Other: Human Allograft (Theraskin) Sponsor: Soluble Systems, LLC Completed
CONCLUSIONS: Although significance was not established because of sample size, there was a definite trend toward significance that merits further investigation with human amniotic allograft.
Condition: Diabetic Foot Intervention: Other: Revita Allograft Sponsor: StimLabs Recruiting